Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

FORTE - a multipurpose high-vacuum diffractometer for tender X-ray diffraction and spectroscopy at the SIRIUS beamline of Synchrotron SOLEIL.

Ciatto G, Aubert N, Lecroard M, Engblom C, Fontaine P, Dubuisson JM, Abiven YM, Janolin PE, Kiat JM, Dumont Y, Berini B, Fouchet A, Keller N.

J Synchrotron Radiat. 2019 Jul 1;26(Pt 4):1374-1387. doi: 10.1107/S1600577519003722. Epub 2019 May 23.

PMID:
31274467
2.

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer.

Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, Martin T, Xia L, Yang H, Li Q, Chen J, Durand S, Aprahamian F, Lefevre D, Broutin S, Paci A, Bongers A, Minard-Colin V, Tartour E, Zitvogel L, Apetoh L, Ma Y, Pittet MJ, Kepp O, Kroemer G.

Nat Commun. 2019 Apr 17;10(1):1883. doi: 10.1038/s41467-019-09838-y.

3.

Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species.

Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, Krishnan I, Maroni G, Meyerovitz CV, Kerwin CM, Choi S, Richards WG, De Rienzo A, Tenen DG, Bueno R, Levantini E, Pittet MJ, Klein AM.

Immunity. 2019 May 21;50(5):1317-1334.e10. doi: 10.1016/j.immuni.2019.03.009. Epub 2019 Apr 9.

PMID:
30979687
4.

Crizotinib-induced immunogenic cell death in non-small cell lung cancer.

Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, Martin T, Xia L, Yang H, Li Q, Chen J, Durand S, Aprahamian F, Lefevre D, Broutin S, Paci A, Bongers A, Minard-Colin V, Tartour E, Zitvogel L, Apetoh L, Ma Y, Pittet MJ, Kepp O, Kroemer G.

Nat Commun. 2019 Apr 2;10(1):1486. doi: 10.1038/s41467-019-09415-3. Erratum in: Nat Commun. 2019 Apr 17;10(1):1883.

5.

Glucocorticoids Regulate Bone Marrow B Lymphopoiesis After Stroke.

Courties G, Frodermann V, Honold L, Zheng Y, Herisson F, Schloss MJ, Sun Y, Presumey J, Severe N, Engblom C, Hulsmans M, Cremer S, Rohde D, Pittet MJ, Scadden DT, Swirski FK, Kim DE, Moskowitz MA, Nahrendorf M.

Circ Res. 2019 Apr 26;124(9):1372-1385. doi: 10.1161/CIRCRESAHA.118.314518.

PMID:
30782088
6.

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.

Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C, Engblom C, Pfirschke C, Siwicki M, Gungabeesoon J, Freeman GJ, Warren SE, Ong S, Browning E, Twitty CG, Pierce RH, Le MH, Algazi AP, Daud AI, Pai SI, Zippelius A, Weissleder R, Pittet MJ.

Immunity. 2018 Dec 18;49(6):1148-1161.e7. doi: 10.1016/j.immuni.2018.09.024. Epub 2018 Dec 11.

PMID:
30552023
7.

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.

Engblom C, Pfirschke C, Zilionis R, Da Silva Martins J, Bos SA, Courties G, Rickelt S, Severe N, Baryawno N, Faget J, Savova V, Zemmour D, Kline J, Siwicki M, Garris C, Pucci F, Liao HW, Lin YJ, Newton A, Yaghi OK, Iwamoto Y, Tricot B, Wojtkiewicz GR, Nahrendorf M, Cortez-Retamozo V, Meylan E, Hynes RO, Demay M, Klein A, Bredella MA, Scadden DT, Weissleder R, Pittet MJ.

Science. 2017 Dec 1;358(6367). pii: eaal5081. doi: 10.1126/science.aal5081.

8.

Moiré method for nanometer instability investigation of scanning hard x-ray microscopes.

Vogt U, Köhler D, Dickmann J, Rahomäki J, Parfeniukas K, Kubsky S, Alves F, Langlois F, Engblom C, Stankevič T.

Opt Express. 2017 May 29;25(11):12188-12194. doi: 10.1364/OE.25.012188.

PMID:
28786577
9.

Interferometric characterization of rotation stages for X-ray nanotomography.

Stankevič T, Engblom C, Langlois F, Alves F, Lestrade A, Jobert N, Cauchon G, Vogt U, Kubsky S.

Rev Sci Instrum. 2017 May;88(5):053703. doi: 10.1063/1.4983405.

PMID:
28571450
10.

Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts.

Miller MA, Chandra R, Cuccarese MF, Pfirschke C, Engblom C, Stapleton S, Adhikary U, Kohler RH, Mohan JF, Pittet MJ, Weissleder R.

Sci Transl Med. 2017 May 31;9(392). pii: eaal0225. doi: 10.1126/scitranslmed.aal0225.

11.

Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.

Cuccarese MF, Dubach JM, Pfirschke C, Engblom C, Garris C, Miller MA, Pittet MJ, Weissleder R.

Nat Commun. 2017 Feb 8;8:14293. doi: 10.1038/ncomms14293.

12.

PF4 Promotes Platelet Production and Lung Cancer Growth.

Pucci F, Rickelt S, Newton AP, Garris C, Nunes E, Evavold C, Pfirschke C, Engblom C, Mino-Kenudson M, Hynes RO, Weissleder R, Pittet MJ.

Cell Rep. 2016 Nov 8;17(7):1764-1772. doi: 10.1016/j.celrep.2016.10.031.

13.

Gal3 Links Inflammation and Insulin Resistance.

Siwicki M, Engblom C, Pittet MJ.

Cell Metab. 2016 Nov 8;24(5):655-656. doi: 10.1016/j.cmet.2016.10.014.

14.

The role of myeloid cells in cancer therapies.

Engblom C, Pfirschke C, Pittet MJ.

Nat Rev Cancer. 2016 Jul;16(7):447-62. doi: 10.1038/nrc.2016.54. Review.

PMID:
27339708
15.

SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions.

Pucci F, Garris C, Lai CP, Newton A, Pfirschke C, Engblom C, Alvarez D, Sprachman M, Evavold C, Magnuson A, von Andrian UH, Glatz K, Breakefield XO, Mempel TR, Weissleder R, Pittet MJ.

Science. 2016 Apr 8;352(6282):242-6. doi: 10.1126/science.aaf1328. Epub 2016 Mar 17.

16.

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.

Pfirschke C, Engblom C, Rickelt S, Cortez-Retamozo V, Garris C, Pucci F, Yamazaki T, Poirier-Colame V, Newton A, Redouane Y, Lin YJ, Wojtkiewicz G, Iwamoto Y, Mino-Kenudson M, Huynh TG, Hynes RO, Freeman GJ, Kroemer G, Zitvogel L, Weissleder R, Pittet MJ.

Immunity. 2016 Feb 16;44(2):343-54. doi: 10.1016/j.immuni.2015.11.024. Epub 2016 Feb 9.

17.

Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.

Miller MA, Gadde S, Pfirschke C, Engblom C, Sprachman MM, Kohler RH, Yang KS, Laughney AM, Wojtkiewicz G, Kamaly N, Bhonagiri S, Pittet MJ, Farokhzad OC, Weissleder R.

Sci Transl Med. 2015 Nov 18;7(314):314ra183. doi: 10.1126/scitranslmed.aac6522.

18.

Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug.

Miller MA, Zheng YR, Gadde S, Pfirschke C, Zope H, Engblom C, Kohler RH, Iwamoto Y, Yang KS, Askevold B, Kolishetti N, Pittet M, Lippard SJ, Farokhzad OC, Weissleder R.

Nat Commun. 2015 Oct 27;6:8692. doi: 10.1038/ncomms9692.

19.

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, Fend L, Hannani D, Aymeric L, Ma Y, Niso-Santano M, Kepp O, Schultze JL, Tüting T, Belardelli F, Bracci L, La Sorsa V, Ziccheddu G, Sestili P, Urbani F, Delorenzi M, Lacroix-Triki M, Quidville V, Conforti R, Spano JP, Pusztai L, Poirier-Colame V, Delaloge S, Penault-Llorca F, Ladoire S, Arnould L, Cyrta J, Dessoliers MC, Eggermont A, Bianchi ME, Pittet M, Engblom C, Pfirschke C, Préville X, Uzè G, Schreiber RD, Chow MT, Smyth MJ, Proietti E, André F, Kroemer G, Zitvogel L.

Nat Med. 2014 Nov;20(11):1301-9. doi: 10.1038/nm.3708. Epub 2014 Oct 26.

PMID:
25344738
20.

Clonal differences in IgE antibodies affect cutaneous anaphylaxis-associated thermal sensitivity in mice.

Mack M, Tonc E, Ashbaugh A, Wetzel A, Sykes A, Engblom C, Shabani E, Mora-Solano C, Trier A, Swanson L, Ewan E, Martinov T, Chatterjea D.

Immunol Lett. 2014 Nov;162(1 Pt A):149-58. doi: 10.1016/j.imlet.2014.08.007. Epub 2014 Aug 19.

21.

Potentiation of natural killer cell activity with myricetin.

Lindqvist C, Bobrowska-Hägerstrand M, Mrówczyńska L, Engblom C, Hägerstrand H.

Anticancer Res. 2014 Aug;34(8):3975-9.

PMID:
25075019
22.

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.

Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Bérard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Doré J, Kroemer G, Lepage P, Boneca IG, Ghiringhelli F, Zitvogel L.

Science. 2013 Nov 22;342(6161):971-6. doi: 10.1126/science.1240537.

23.

Remote control of macrophage production by cancer.

Cortez-Retamozo V, Engblom C, Pittet MJ.

Oncoimmunology. 2013 May 1;2(5):e24183.

24.

Mast cell degranulation mediates compound 48/80-induced hyperalgesia in mice.

Chatterjea D, Wetzel A, Mack M, Engblom C, Allen J, Mora-Solano C, Paredes L, Balsells E, Martinov T.

Biochem Biophys Res Commun. 2012 Aug 24;425(2):237-43. doi: 10.1016/j.bbrc.2012.07.074. Epub 2012 Jul 22.

25.

An evaluation of on-site oral fluid drug screening devices DrugWipe 5+ and Rapid STAT using oral fluid for confirmation analysis.

Pehrsson A, Blencowe T, Vimpari K, Langel K, Engblom C, Lillsunde P.

J Anal Toxicol. 2011 May;35(4):211-8.

PMID:
21513614
26.

Sex education in Swedish schools as described by young women.

Ekstrand M, Engblom C, Larsson M, Tydén T.

Eur J Contracept Reprod Health Care. 2011 Jun;16(3):210-24. doi: 10.3109/13625187.2011.561937. Epub 2011 Mar 17.

PMID:
21413866
27.

Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin-1 expression.

Ribbing C, Engblom C, Lappalainen J, Lindstedt K, Kovanen PT, Karlsson MA, Lundeberg L, Johansson C, Nilsson G, Lunderius-Andersson C, Scheynius A.

Allergy. 2011 Jan;66(1):110-9. doi: 10.1111/j.1398-9995.2010.02437.x.

PMID:
20608913
28.

TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis.

Selander C, Engblom C, Nilsson G, Scheynius A, Andersson CL.

J Immunol. 2009 Apr 1;182(7):4208-16. doi: 10.4049/jimmunol.0800885.

29.

Drug testing in oral fluid-evaluation of sample collection devices.

Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P.

J Anal Toxicol. 2008 Jul-Aug;32(6):393-401.

PMID:
18652744
31.

Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.

Pehrsson A, Gunnar T, Engblom C, Seppä H, Jama A, Lillsunde P.

Forensic Sci Int. 2008 Mar 5;175(2-3):140-8. Epub 2007 Jul 20.

PMID:
17640837
32.

Driving under the influence of drugs--amphetamine concentrations in oral fluid and whole blood samples.

Engblom C, Gunnar T, Rantanen A, Lillsunde P.

J Anal Toxicol. 2007 Jun;31(5):276-80.

PMID:
17579972
33.

Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.

Frølund B, Jørgensen AT, Tagmose L, Stensbøl TB, Vestergaard HT, Engblom C, Kristiansen U, Sanchez C, Krogsgaard-Larsen P, Liljefors T.

J Med Chem. 2002 Jun 6;45(12):2454-68.

PMID:
12036354
34.

A novel class of potent 3-isoxazolol GABA(A) antagonists: design, synthesis, and pharmacology.

Frølund B, Tagmose L, Liljefors T, Stensbøl TB, Engblom C, Kristiansen U, Krogsgaard-Larsen P.

J Med Chem. 2000 Dec 28;43(26):4930-3. No abstract available.

PMID:
11150163
35.
36.

[Review of standards for ambulances].

Engblom CE.

Tidskr Sver Sjukskot. 1966 Aug;33(14):650. Swedish. No abstract available.

PMID:
5178629
37.

[New material and a new style].

Engblom CE.

Tidskr Sver Sjukskot. 1966 Apr 12;33(7):322-4. Swedish. No abstract available.

PMID:
5176930
38.

[REVISION OF THE SWEDISH STANDARD FOR AMBULANCES, PATIENT CARS AND STRETCHERS].

ENGBLOM CE.

Sven Lakartidn. 1964 Dec 9;61:3926-41. Swedish. No abstract available.

PMID:
14268746

Supplemental Content

Loading ...
Support Center